EXCLUSIVE-Oxford study indicates AstraZeneca effective against Brazil variant, source says

The information comes as a small-sample study suggested the COVID-19 vaccine developed by China's Sinovac may not work effectively against the Brazilian variant. Responding to a request for comment, Fiocruz, which sent the samples that formed the basis of the study, told Reuters it did not have any information on the study, as it was being led by AstraZeneca and the University of Oxford.

Reuters | Brasilia | Updated: 05-03-2021 20:00 IST | Created: 05-03-2021 19:58 IST
EXCLUSIVE-Oxford study indicates AstraZeneca effective against Brazil variant, source says
Representative Image Image Credit: ANI

Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday.

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have originated in the Amazonian city of Manaus, said the source, who requested anonymity as the results have not yet been made public. The source did not provide the exact efficacy of the vaccine against the variant. They said the full results of the study should be released soon, possibly in March.

Early results indicated the AstraZeneca vaccine was less effective against the South African variant, which is similar to P1. South Africa subsequently paused the use of the vaccine in the country. The information comes as a small-sample study suggested the COVID-19 vaccine developed by China's Sinovac may not work effectively against the Brazilian variant.

Responding to a request for comment, Fiocruz, which sent the samples that formed the basis of the study, told Reuters it did not have any information on the study, as it was being led by AstraZeneca and the University of Oxford. Representatives for AstraZeneca and the University of Oxford did not immediately respond to requests for comment.

Brazil is currently confronting a brutal and long-lasting second wave of the coronavirus, hitting a daily record of 1,910 deaths on Wednesday. The P1 variant is among the factors that epidemiologists believe is contributing to a rise in cases and deaths, and there has been concern in the scientific community about the variant's resistance to vaccines.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

West Bengal elections: 36.02 per cent voter turnout recorded till 11 am in 45 seats where polling is underway for fifth phase.

West Bengal elections 36.02 per cent voter turnout recorded till 11 am in 45 seats where polling is underway for fifth phase....

The Tokyo Olympics will go on, but in name only

In 1964, less than two decades removed from World War II, Japan used the Summer Olympics to showcase its astonishing recovery from a horrific defeat.It was an undeniable triumph for the host nation.This time, the Tokyo Games will be a multi...

Myanmar releases prisoners for New Year, though likely not dissidents

Myanmars junta released 23,184 prisoners from jails across the country on Saturday under a New Year amnesty, a Prisons Department spokesman said, though few if any democracy activists arrested since a Feb. 1 coup were thought to be among th...

As part of state-wide mass testing for COVID-19, Kerala's Ernakulam collects over 16,000 samples

As part of a State-wide mass testing drive to contain the spread of COVID-19, Keralas Ernakulam district has collected 16,210 samples for testing on Friday, District Collector S Suhas said. In an official statement, the Collector said We wi...

Give Feedback